- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04197362
Everyday Activity Shoes: a Quantification of Impact Forces While Walking
November 28, 2023 updated by: David T. Burke, Emory University
This study aims to directly compare traditional everyday activity shoes (ASICS, Nike) with a shoe created to be flatter, less cushioned, and with less cradling of the foot (OESH shoe).
Study Overview
Detailed Description
This study addresses a common question in popular media: what attributes of traditional everyday activity shoes (Nike, New Balance, etc.) make a shoe better or worse.
There have been several peer-reviewed studies aimed to answer this by calculating forces and torques at the ankles, knees, and hips while subjects wore shoes with different properties.
Such characteristics include heel size, cushioning and side-to-side cradling of the foot.
Interestingly, most studies have shown that the lack of a heel, less cushioning, and less cradling of the foot actually improve the biomechanics related to forces and torques, thus decreasing wear and tear on the cartilage and bones of the leg.
Wear and tear on cartilage and bone may predispose patients to a bone condition called "osteoarthritis", which is a disease where bones become damaged from rubbing on each other with breakdown of a cartilage "cushion".
This study thus aims to directly compare traditional everyday activity shoes (ASICS, Nike) with a shoe created to be flatter, less cushioned, and with less cradling of the foot (OESH shoe).
Study Type
Interventional
Enrollment (Estimated)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David Burke, MD, MA
- Phone Number: 404-712-1899
- Email: dburke2@emory.edu
Study Contact Backup
- Name: Gina Bell, MPH
- Phone Number: 404-712-1899
- Email: burke.research@emory.edu
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Recruiting
- Emory Rehabilitation Hospital
-
Contact:
- David Burke, MD, MA
- Phone Number: 404-712-5507
- Email: DBURKE2@emory.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Women between the ages of 18-65
- Women who identify as "healthy"
- Women who run or walk for exercise more than three times per week
- Women in the Atlanta, Georgia area
Exclusion Criteria:
- Individuals with history of significant musculoskeletal pathology
- Individuals with musculoskeletal injury at time of testing
- Individuals unable to consent
- Individuals outside of the ages 18-65
- Individuals who are prisoners
- Individuals who do not speak or write in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ASICS Women's Gel-Venture 6 Running-Shoe
|
Subjects will be asked to walk across the gait laboratory floor at their self-selected walking speed.
They will complete a 3-5 minute warm up period, as it was found to produce stable estimates of kinetic parameter mean values during treadmill activity.
The positions of each marker will be recorded through the motion capture system.
Ground reaction force will be obtained in real time from the gait laboratory force plates as marker dimensions are recorded.
For walking data, two trials of 15 seconds each will be recorded.
The second trial will be a redundancy in the setting of potential significant marker dropout.
|
Experimental: Nike Air Max 270
|
Subjects will be asked to walk across the gait laboratory floor at their self-selected walking speed.
They will complete a 3-5 minute warm up period, as it was found to produce stable estimates of kinetic parameter mean values during treadmill activity.
The positions of each marker will be recorded through the motion capture system.
Ground reaction force will be obtained in real time from the gait laboratory force plates as marker dimensions are recorded.
For walking data, two trials of 15 seconds each will be recorded.
The second trial will be a redundancy in the setting of potential significant marker dropout.
|
Experimental: La Vida+
|
Subjects will be asked to walk across the gait laboratory floor at their self-selected walking speed.
They will complete a 3-5 minute warm up period, as it was found to produce stable estimates of kinetic parameter mean values during treadmill activity.
The positions of each marker will be recorded through the motion capture system.
Ground reaction force will be obtained in real time from the gait laboratory force plates as marker dimensions are recorded.
For walking data, two trials of 15 seconds each will be recorded.
The second trial will be a redundancy in the setting of potential significant marker dropout.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Differences in torques at the knee comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in forces at the knee comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Differences in torques at the bilateral anterior and posterior superior spine comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in forces at the bilateral anterior and posterior superior spine comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in torques at the lateral femoral condyles comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in forces at the lateral femoral condyles comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in torques at the lateral mid-shanks comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in forces at the lateral mid-shanks comparing three study arms
Time Frame: One-time at enrollment, no follow-up day
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up day
|
Differences in torques at the lateral malleoli comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in forces at the lateral malleoli comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in torques at the second metatarsal heads comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in forces at the second metatarsal heads comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in torques at the heels comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Differences in forces at the heels comparing three study arms
Time Frame: One-time at enrollment, no follow-up
|
Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed.
In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait.
Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.
|
One-time at enrollment, no follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Burke, MD, MA, Emory University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 19, 2023
Primary Completion (Estimated)
March 1, 2024
Study Completion (Estimated)
March 1, 2024
Study Registration Dates
First Submitted
December 11, 2019
First Submitted That Met QC Criteria
December 11, 2019
First Posted (Actual)
December 13, 2019
Study Record Updates
Last Update Posted (Actual)
November 29, 2023
Last Update Submitted That Met QC Criteria
November 28, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00112113
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data (IPD) will not be shared
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Impact Forces
-
Central Hospital, Nancy, FranceCompletedInformation Understanding and Psychological ImpactFrance
-
Faculdade de Motricidade HumanaCompletedFacemask Impact on Cardiorespiratory PerformancePortugal
-
Ospedale Regionale Bellinzona e ValliCompletedImpact of Anesthetic Choice on Costs
-
University Hospital, Strasbourg, FranceCompletedStudy the Impact of Head Position
-
National Taiwan University HospitalUnknownEvaluate the Impact of the CDSSTaiwan
-
University of MichiganCompletedthe Impact of Platform-switchingUnited States
-
University of California, San FranciscoFood and Drug Administration (FDA)RecruitingThe Impact of Excipients on Drug AbsorptionUnited States
-
Ottawa Hospital Research InstituteUniversity of Manitoba; University of British Columbia; McGill University; McMaster... and other collaboratorsUnknown
-
RWTH Aachen UniversityUnknownThe Impact of Oxytocin on Social CognitionGermany
-
Northwell HealthOrganonTerminatedSperm DNA Impact on ART OutcomesUnited States
Clinical Trials on Evaluation
-
IRCCS Eugenio MedeaCompletedIntellectual Disability | Autism Spectrum Disorder | Attention Deficit Hyperactivity DisorderItaly
-
University Hospital, BordeauxRoche Pharma AGRecruitingMultiple Sclerosis, Primary ProgressiveFrance
-
University Hospital, BordeauxRecruitingMultiple SclerosisFrance
-
University Hospital, CaenRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Motoric Cognitive Risk SyndromeFrance
-
University of CatanzaroAzienda Sanitaria Provinciale Di Catanzaro; Azienda Ospedaliera Universitaria...Unknown
-
Ankara Yildirim Beyazıt UniversityCompletedType 2 Diabetes Mellitus | BalanceTurkey
-
Wake Forest University Health SciencesAgency for Healthcare Research and Quality (AHRQ)Recruiting
-
Kırıkkale UniversityCompleted
-
Institut National de la Santé Et de la Recherche...Terminated